Study suggests Eli Lilly’s weight-loss medication may reduce signals for binge eating.
Researchers studying brain activity in patients with significant overeating issues found that Eli Lilly’s weight loss medicine, GLP-1, seems to temporarily reduce hunger signals in the brain’s “reward center.” This marks the first time direct brain activity measurements have been taken from individuals receiving tirzepatide—marketed as Mounjaro for diabetes and Zepbound for weight loss—which showcased […]
Trump plans to reveal reduced prices for weight-loss medications and broader Medicare eligibility.
Trump’s Announcement on Drug Price Reductions Later today, President Trump is set to reveal that two prominent pharmaceutical companies will be cutting the prices of GLP-1 medications, which are often used for diabetes treatment and weight management. Additionally, the government plans to broaden eligibility for these drugs under Medicare. Novo Nordisk, based in Denmark, produces […]
Brooks Nader acknowledges reliance on GLP-1 drugs, describes weight-loss medications as ‘a support’
Brooks Nader Addresses Weight Loss Drug Addiction Model Brooks Nader recently opened up about her ongoing struggle with addiction to weight loss drugs, despite her sisters’ intervention, which revealed a basket full of needles in her possession. During an episode of her reality show, “Love Thy Nader,” viewers saw Nader’s sisters confront her after finding […]
Americans are relying on unregulated sellers for GLP-1 weight-loss medications.
Concerns Rise Over Unregulated GLP-1 Drug Sales As interest in GLP-1 medications surges, particularly for weight loss and diabetes management, many Americans are opting for unregulated sellers instead of traditional pharmacies. This shift often stems from high costs, insurance issues, and consistent shortages. The FDA has issued warnings regarding the “gray market” for GLP-1 drugs, […]
Weight-loss physician explains how GLP-1 medications also address chronic illness
Recent research indicates that weight loss and diabetes medications, known as glucagon-like peptide-1 receptor agonists (GLP-1), could be beneficial for a range of other health issues. These issues include cardiovascular disease, arthritis, skin conditions, and potentially even cancer prevention. The use of these drugs is linked to a reduced risk of chronic diseases, with a […]
Fans criticize Serena Williams for promoting a ‘dangerous’ message by discussing her use of weight-loss medication.
Serena Williams has faced backlash from fans after disclosing that she lost over 30 pounds using weight loss medication. On Thursday, the medical company RO released a joint post on Instagram to promote its partnership with the tennis champion. In the video, 43-year-old Williams appeared to administer weekly injections. Many fans expressed their disappointment in […]
Serena Williams shares her reasons for using a weight-loss medication and losing 31 pounds.
Serena Williams shared that after the birth of her two children, she sought help from GLP-1 weight loss medications to assist her in shedding pounds. At 43 years old, Williams mentioned in an interview that she lost 31 pounds over the course of eight months with the help of these medications. “I literally tried everything. […]
Giving up ultra-processed foods might double your weight-loss success, research indicates
Study Highlights Impact of Eliminating Ultra-Processed Foods on Weight Loss A recent study indicates that avoiding a specific type of food can nearly double the results of weight loss efforts. Published on August 4 in the journal Nature Medicine, it reveals that overweight adults who stopped consuming ultra-processed foods (UPFs) lost almost twice the weight […]
Weight-loss medications associated with higher chances of eye problems and vision impairment
Recent research indicates that some weight loss medications may be linked to a heightened risk of serious eye conditions, including potential vision loss. Two studies featured in Jama examined the effects of semaglutide and tilzepatide—common drugs like Ozempic, Wegovy, Munjaro, and Zepbound—on the eye health of Americans diagnosed with Type 2 diabetes over a two-year […]
Diabetes and weight-loss medications might also help with arthritis symptoms.
The Benefits of GLP-1 Drugs Extend Beyond Diabetes and Weight Loss GLP-1 drugs, known for mimicking a hormone that regulates blood sugar, might have effects beyond managing diabetes and aiding in weight loss. Experts suggest that medications like semaglutide (Ozempic, Wegovy) and tilzepatide (Munjaro, Zepbound) could offer relief for those suffering from rheumatoid arthritis (RA). […]